Tamarly Intelligence
Company · IAM (NASDAQ - All Markets)

Iambic Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)

Key figures
Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
SEC number
1997038

Source: SEC EDGAR filings and company facts; checked 19 Oct 2026

Rounds and raises
9 Sept 2026
Form D: $66M sold of $67M offered, Biotechnology SEC
8 Apr 2026
Form D: $28M sold of $50M offered, Biotechnology SEC
21 Nov 2025
Form D: $99M sold of $125M offered, Biotechnology SEC

Source: SEC EDGAR Form D and the linked articles. All raises this week

Questions and answers

Where is Iambic Therapeutics, Inc. listed?
Iambic Therapeutics, Inc. trades as IAM on NASDAQ - All Markets. Tamarly shows no share prices.
With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Iambic Therapeutics, Inc.: IAM, rounds, investors and filings | Tamarly